| |||
 | |||
 |
Creatine | ||
|
| |||
|
| U.S. Brand Names |
| AsthmaNefrin®; microNefrin®; Nephron®; S-2®; Vaponefrin® |
 |
| Generic Available |
|
Yes |
|
| Pharmacological Index |
|
Alpha/Beta Agonist; Vasoconstrictor |
|
| Adverse Reactions |
|
No data reported |
|
| Drug Interactions |
|
No data reported |
|
| Pharmacodynamics/Kinetics |
|
Absorption: Not absorbed orally Onset of bronchodilation: Subcutaneous: Within 5-10 minutes Inhalation: Within 1 minute |
|
| Dietary Considerations |
|
No data reported |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Dosage Forms |
|
Solution, inhalation: Vaponefrin®: Racepinephrine 2% [epinephrine base 1%] (15 mL, 30 mL) |
|
|
Copyright © 2007 Drugs Area |
